Latest News about COVID/19 Vaccine
Recent news which mentions COVID/19 Vaccine
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 14, 2024
From Benzinga
Netflix, TSMC, American Express, Moderna, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 17, 2024
From Benzinga
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
October 16, 2024
From Benzinga
Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim
April 03, 2024
From Benzinga
CDC Urges Second COVID-19 Vaccine Dose For Elderly Americans Amid Rising Hospitalizations
February 29, 2024
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
From Benzinga
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
From Benzinga
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
From Benzinga
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute
October 05, 2023
From Benzinga
Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?
September 20, 2023
From Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
September 13, 2023
From Benzinga
Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?
September 06, 2023
Tickers
MRNA
From Benzinga
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns
September 01, 2023
From Benzinga
Money Stolen On Account COVID-19 Relief Fund Fraud is Shocking! US Justice Department Cracks Whip
August 24, 2023
From Benzinga
From Benzinga
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
August 18, 2023
From Benzinga
Moderna Seeks European Nod For Updated COVID-19 Vaccine Shot To Tackle New Dominant Strain
July 03, 2023
Tickers
MRNA
From Benzinga
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
June 26, 2023
From Benzinga
Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support
June 16, 2023
From Benzinga
Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech
June 07, 2023
From Benzinga
From Benzinga
From Benzinga
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
May 25, 2023
From Benzinga
From Benzinga
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
May 01, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|